Chiropractors in Larned, KS Accepting Medicare
5 Chiropractors found. Showing 1 - 5
 Dr. Stephen E. Dent, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1202 W 11th St, Larned, KS 67550 Phone: 620-285-6909 Fax: 620-285-6909 |
 Dr. Lindsey M Vansickle, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 606 Topeka St, Larned, KS 67550 Phone: 620-285-6190 Fax: 620-285-6189 |
 Perez Chiropractic Clinic, Pa Chiropractor Medicare: Medicare Enrolled Practice Location: 313 W 14th St, Larned, KS 67550 Phone: 620-285-6600 Fax: 620-285-6600 |
Healthy Living Chiropractic, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 606 Topeka St, Larned, KS 67550 Phone: 620-338-1994 |
Mr. Luis Alberto Perez, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 313 W 14th, Larned, KS 67550 Phone: 620-285-6600 Fax: 620-285-6600 |
News Archive
UW researchers develop smartphone app that detects newborn jaundice within minutes
University of Washington engineers and physicians have developed a smartphone application that checks for jaundice in newborns and can deliver results to parents and pediatricians within minutes. It could serve as a screening tool to determine whether a baby needs a blood test - the gold standard for detecting high levels of bilirubin.
Discovery of new syndrome associated with severe congenital neutropenia
A team of scientists has discovered a new syndrome associated with severe congenital neutropenia (SCN), a rare disorder in which children lack sufficient infection-fighting white cells, and identified the genetic cause of the syndrome: mutations in the gene Glucose-6-phosphatase, catalytic subunit 3 (G6PC3).
Wal-Mart increases premium costs, cuts benefits
Costs for this employer's most popular health coverage plan will increase to about $15 per two-week pay period. It's current cost is $11 per pay period.
Latrepirdine appears effective in treating Alzheimer's disease in animals
An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped the progression of memory deterioration and brain pathology in mouse models of early stage Alzheimer's disease.
› Verified 3 days ago
Chiropractors
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Optometrists